Related references
Note: Only part of the references are listed.The Effects of Botulinum Toxin A on Survival of Rat TRAM Flap With Vertical Midline Scar
Tae Hwan Park et al.
ANNALS OF PLASTIC SURGERY (2015)
Protective effect of botulinum toxin A after cutaneous ischemia-reperfusion injury
Akihiko Uchiyama et al.
SCIENTIFIC REPORTS (2015)
No association of atherosclerosis with digital ulcers in Japanese patients with systemic sclerosis: Evaluation of carotid intima-media thickness and plaque characteristics
Sei-ichiro Motegi et al.
JOURNAL OF DERMATOLOGY (2014)
A prospective study of the use of botulinum toxin injections in the treatment of Raynaud's syndrome associated with scleroderma
L. Uppal et al.
JOURNAL OF HAND SURGERY-EUROPEAN VOLUME (2014)
Potential application of in vivo imaging of impaired lymphatic duct to evaluate the severity of pressure ulcer in mouse model
Akira Kasuya et al.
SCIENTIFIC REPORTS (2014)
2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative
Frank van den Hoogen et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Cervical dystonia: From pathophysiology to pharmacotherapy
Sejal Patel et al.
BEHAVIOURAL NEUROLOGY (2013)
Botulinum toxin A and B raise blood flow and increase survival of critically ischemic skin flaps
Dennis F. Schweizer et al.
JOURNAL OF SURGICAL RESEARCH (2013)
A pilot study evaluating the efficacy of botulinum toxin A in the treatment of Raynaud phenomenon
Sasha N. Jenkins et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2013)
Botulinum Toxin-A for the Treatment of Raynaud Syndrome
David Polsky
ARCHIVES OF DERMATOLOGY (2012)
Concurrent OnabotulinumtoxinA Treatment of Cervical Dystonia and Concomitant Migraine
Paul K. Winner et al.
HEADACHE (2012)
The pathogenesis, diagnosis and treatment of Raynaud phenomenon
Ariane L. Herrick
NATURE REVIEWS RHEUMATOLOGY (2012)
Botulinum Toxin A Treatment of Raynaud's Phenomenon: A Review
Matthew L. Iorio et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2012)
Botulinum toxin for neurogenic bladder dysfunction
H. Schulte-Baukloh
UROLOGE (2012)
Botulinum toxin assessment, intervention and aftercare for lower limb disorders of movement and muscle tone in adults: international consensus statement
J. Olver et al.
EUROPEAN JOURNAL OF NEUROLOGY (2010)
Mechanisms of skin fibrosis in systemic sclerosis
Masatoshi Jinnin
JOURNAL OF DERMATOLOGY (2010)
Future treatments in systemic sclerosis
Yoshihide Asano
JOURNAL OF DERMATOLOGY (2010)
Botulinum Toxin Type A in the Treatment of Raynaud's Phenomenon
Michael W. Neumeister
JOURNAL OF HAND SURGERY-AMERICAN VOLUME (2010)
Peptide-mediated transdermal delivery of botulinum neurotoxin type A reduces neurogenic inflammation in the skin
Nicole M. E. Carmichael et al.
PAIN (2010)
Effect of the dual endothelin receptor antagonist bosentan on Raynaud's phenomenon secondary to systemic sclerosis: a double-blind prospective, randomized, placebo-controlled pilot study
Van Anh Nguyen et al.
RHEUMATOLOGY (2010)
Efficacy of tadalafil in secondary Raynaud's phenomenon resistant to vasodilator therapy: a double-blind randomized cross-over trial
Padmanabha D. Shenoy et al.
RHEUMATOLOGY (2010)
Botulinum Toxin Type A: A Treatment Option for Digital Ischemia in Patients With Raynaud's Phenomenon
Alero Fregene et al.
JOURNAL OF HAND SURGERY-AMERICAN VOLUME (2009)
The effects of botulinum toxin A on the survival of a random cutaneous flap
Taek Kyun Kim et al.
JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY (2009)
Botox Therapy for Ischemic Digits
Michael W. Neumeister et al.
PLASTIC AND RECONSTRUCTIVE SURGERY (2009)
The effect of botulinum toxin A on skin flap survival in rats
Young Seok Kim et al.
WOUND REPAIR AND REGENERATION (2009)
The clinical relevance of serum antinuclear antibodies in Japanese patients with systemic sclerosis
Y. Hamaguchi et al.
BRITISH JOURNAL OF DERMATOLOGY (2008)
Regulation of vascular reactivity in scleroderma: New insights into Raynaud's phenomenon
Nicholas A. Flavahan
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2008)
Synaptobrevin I mediates exocytosis of CGRP from sensory neurons and inhibition by botulinum toxins reflects their anti-nociceptive potential
Jianghui Meng et al.
JOURNAL OF CELL SCIENCE (2007)
Management of vasospastic disorders with botulinum toxin A
Allen L. Van Beek et al.
PLASTIC AND RECONSTRUCTIVE SURGERY (2007)
Pain: a review of three commonly used pain rating scales
A Williamson et al.
JOURNAL OF CLINICAL NURSING (2005)
Reactive oxygen species from smooth muscle mitochondria initiate cold-induced constriction of cutaneous arteries
SR Bailey et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2005)
Botulinum toxin in the treatment of Raynaud's phenomenon: a pilot study
T Sycha et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2004)
Regulation of calcitonin gene-related peptide secretion from trigeminal nerve cells by botulinum toxin type A: Implications for migraine therapy
PL Durham et al.
HEADACHE (2004)
Raynaud's phenomenon.
FM Wigley
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon
PA Merkel et al.
ARTHRITIS AND RHEUMATISM (2002)
Share Paper
